Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Terns Pharmaceuticals, Inc. | Chief Medical Officer | Common Stock | 58.8K | $222K | $3.78 | Mar 10, 2024 | Direct |
Calithera Biosciences, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 3.54K | $1.37K | $0.39 | Jan 23, 2023 | Direct |
Terns Pharmaceuticals, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 120K | Dec 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TERN | Terns Pharmaceuticals, Inc. | Dec 12, 2024 | 1 | $0 | 4 | Dec 16, 2024 | Chief Medical Officer |
TERN | Terns Pharmaceuticals, Inc. | Mar 10, 2024 | 0 | $0 | 3 | Mar 19, 2024 | Chief Medical Officer |
CALA | Calithera Biosciences, Inc. | Jan 23, 2023 | 1 | -$35 | 4 | Jan 25, 2023 | CHIEF MEDICAL OFFICER |
CALA | Calithera Biosciences, Inc. | Jan 25, 2022 | 1 | $0 | 4 | Jan 27, 2022 | CHIEF MEDICAL OFFICER |
CALA | Calithera Biosciences, Inc. | Jan 21, 2022 | 1 | -$327 | 4 | Jan 25, 2022 | CHIEF MEDICAL OFFICER |
CALA | Calithera Biosciences, Inc. | Jan 4, 2022 | 1 | -$2.55K | 4 | Jan 6, 2022 | CHIEF MEDICAL OFFICER |
CALA | Calithera Biosciences, Inc. | Nov 5, 2021 | 2 | -$2.68K | 4 | Nov 9, 2021 | CHIEF MEDICAL OFFICER |
CALA | Calithera Biosciences, Inc. | Nov 5, 2021 | 0 | $0 | 3 | Nov 9, 2021 | CHIEF MEDICAL OFFICER |